2022
School closures and reopenings during the COVID-19 pandemic: a scoping review protocol
Li D, Nyhan K, Zhou X, Zhu Y, Castro D, Vermund SH, Brault M. School closures and reopenings during the COVID-19 pandemic: a scoping review protocol. BMJ Open 2022, 12: e054292. PMID: 35110320, PMCID: PMC8811274, DOI: 10.1136/bmjopen-2021-054292.Peer-Reviewed Original ResearchMeSH KeywordsChildCOVID-19HumansPandemicsResearch DesignReview Literature as TopicSARS-CoV-2SchoolsSystematic Reviews as TopicConceptsSchool closuresCOVID-19 pandemicWidespread school closuresCitation chainingType of researchSchool safetySchool reopeningSchoolsIndependent third reviewerPaucity of researchCollege studentsSources of evidenceJoanna Briggs Institute methodologyIndividual knowledgePandemicTitle screeningIndividual concernsCOVID-19 evidenceDisease prevention practicesGrey literatureFormal ethical approvalFull-text screeningBroad disseminationTeachersReopening
2018
Partners-based HIV treatment for seroconcordant couples attending antenatal and postnatal care in rural Mozambique: A cluster randomized trial protocol
Audet CM, Graves E, Barreto E, De Schacht C, Gong W, Shepherd BE, Aboobacar A, Gonzalez-Calvo L, Alvim MF, Aliyu MH, Kipp AM, Jordan H, Amico KR, Diemer M, Ciaranello A, Dugdale C, Vermund SH, Van Rompaey S. Partners-based HIV treatment for seroconcordant couples attending antenatal and postnatal care in rural Mozambique: A cluster randomized trial protocol. Contemporary Clinical Trials 2018, 71: 63-69. PMID: 29879469, PMCID: PMC6067957, DOI: 10.1016/j.cct.2018.05.020.Peer-Reviewed Original ResearchConceptsChild transmissionSeroconcordant couplesMale partnersResource-limited rural settingsElimination of motherRoutine clinical dataUptake of servicesClinical trial designMale partner approvalAntiretroviral therapyHIV careAntenatal careRural MozambiqueHIV servicesPostnatal carePregnant womenHIV treatmentTrial protocolClinical dataHealth facilitiesTrial designHIVNewborn childrenPartner approvalEngagement interventions
2016
Substance use and HIV-risk behaviors among HIV-positive men who have sex with men in China: repeated measures in a cohort study design
Zhang C, Liu Y, Sun X, Wang J, Lu HY, He X, Zhang H, Ruan YH, Shao Y, Vermund SH, Qian HZ. Substance use and HIV-risk behaviors among HIV-positive men who have sex with men in China: repeated measures in a cohort study design. AIDS Care 2016, 29: 644-653. PMID: 27832699, PMCID: PMC5350012, DOI: 10.1080/09540121.2016.1255709.Peer-Reviewed Original ResearchConceptsHIV risk behaviorsCohort study designSubstance useStudy designHIV-positive MSMHIV-positive menGeneralized Estimating Equation modelsFemale sex partnersRapid HIV transmissionMale sexual partnersRigorous study designsSexual risk behaviorsCurrent studySeronegative counterpartsSeropositive menSeropositive partnersHIV transmissionMean agePotential confoundersRisk factorsHigh riskRisk populationsSex partnersUnprotected sexRisk behaviors
2014
HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial
Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, Bock P, Griffith S, Moore A, Watson-Jones D, Fraser C, Vermund SH, Fidler S, The HPTN 071 (PopART) Study Team. HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial. Trials 2014, 15: 57. PMID: 24524229, PMCID: PMC3929317, DOI: 10.1186/1745-6215-15-57.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnti-HIV AgentsCircumcision, MaleClinical ProtocolsCost-Benefit AnalysisDrug Administration ScheduleFemaleHealth Care CostsHIV InfectionsHumansIncidenceMaleMass ScreeningPredictive Value of TestsPrevalenceResearch DesignSouth AfricaTime FactorsTreatment OutcomeYoung AdultZambiaConceptsImmediate antiretroviral treatmentAntiretroviral treatmentHIV incidenceHIV testingCombination HIV prevention packageHIV combination prevention interventionsHome-based HIV testingUniversal testingCombination prevention interventionsHIV prevention packageHPTN 071 (PopART) trialUniversal HIV testingHIV-negative menCluster-randomised trialCurrent national guidelinesStandard of careMedical male circumcisionPublic health problemThree-arm designPotential adverse effectsART initiationHPTN 071Testing HIVSecondary outcomesArm B
2013
Optimizing PMTCT service delivery in rural North-Central Nigeria: Protocol and design for a cluster randomized study
Aliyu MH, Blevins M, Audet C, Shepherd BE, Hassan A, Onwujekwe O, Gebi UI, Kalish M, Lindegren ML, Vermund SH, Wester CW. Optimizing PMTCT service delivery in rural North-Central Nigeria: Protocol and design for a cluster randomized study. Contemporary Clinical Trials 2013, 36: 187-197. PMID: 23816493, PMCID: PMC3786261, DOI: 10.1016/j.cct.2013.06.013.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Retroviral AgentsCD4 Lymphocyte CountCost-Benefit AnalysisFamilyFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMaternal-Child Health CentersMentorsNigeriaPatient SatisfactionPoint-of-Care SystemsPregnancyPrenatal CareResearch DesignRural PopulationSocioeconomic FactorsConceptsAntiretroviral therapyPMTCT servicesChild transmissionHIV service integrationPMTCT service deliveryPMTCT service provisionChild HIV transmissionPrevention of motherCell count testingSimilar resource-limited settingsRural health facilitiesRural North-Central NigeriaResource-limited settingsPatient care responsibilitiesPMTCT careMore HIVHIV infectionCare CD4Cell count resultsHIV transmissionPregnant womenUNAIDS/Health facilitiesHealth providersInfluential community membersImpact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique
Shepherd BE, Blevins M, Vaz LM, Moon TD, Kipp AM, José E, Ferreira FG, Vermund SH. Impact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique. American Journal Of Epidemiology 2013, 178: 819-828. PMID: 23785113, PMCID: PMC3755641, DOI: 10.1093/aje/kwt030.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusVisit scheduleKaplan-Meier techniqueRate of mortalityAntiretroviral therapyCumulative incidenceTreatment initiationEstimates of retentionImmunodeficiency syndromeImmunodeficiency virusHIV programsChronic diseasesDisease progressionPatient retentionImpact of definitionsHIV literatureClinical encountersStudy outcomesMortalityAIDSLTFDeathInformative censoringProgram evaluationStudy conclusions
2004
Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa
Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH. Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2004, 36: 831-834. PMID: 15213567, PMCID: PMC2745050, DOI: 10.1097/00126334-200407010-00010.Peer-Reviewed Original ResearchConceptsAntiretroviral clinical trialsClinical trialsActive antiretroviral therapyAvailability of HAARTImpact of nonadherenceResource-constrained countriesResource-limited settingsHome-based care servicesAntiretroviral therapyPublic health contextART availabilityDrug costsClinical careTherapy researchConsensus conferenceViral resistanceResearch prioritiesCare servicesGeneric medicationsSuch trialsTherapeutic resourcesTrialsHAARTHIVUrgent research priority
2003
Developing a Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Therapeutic Research Agenda for Resource-Limited Countries: A Consensus Statement
Vermund SH, Powderly WG, Association of IDSA O. Developing a Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Therapeutic Research Agenda for Resource-Limited Countries: A Consensus Statement. Clinical Infectious Diseases 2003, 37: s4-s12. PMID: 12822127, DOI: 10.1086/375367.Peer-Reviewed Original ResearchConceptsResource-limited countriesAntiretroviral therapyResource-limited settingsDelivery of ARTImmunodeficiency syndrome careClinical Trials NetworkHealth care providersResource limited countriesHealth care practitionersHealth care advocatesHIV diseaseHIV/Consensus statementTreatment accessCare providersCare practitionersTrials NetworkART provisionCare advocatesTherapyMillions of peoplePharmaceutical expertsPatient monitoringCommunity representativesDisease
1998
The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants
Rogers A, Futterman D, Moscicki A, Wilson C, Ellenberg J, Vermund S. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants. Journal Of Adolescent Health 1998, 22: 300-311. PMID: 9561462, DOI: 10.1016/s1054-139x(97)00279-6.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdolescent Health ServicesCohort StudiesComorbidityData CollectionDisease ProgressionFemaleHealth Planning OrganizationsHIV InfectionsHumansMaleMulticenter Studies as TopicProgram DevelopmentProspective StudiesResearchResearch DesignUnited StatesConceptsAdolescent Medicine HIV/AIDS Research NetworkMedical chart abstractionGroup of HIVHIV-negative controlsAIDS Research NetworkHIV-positive youthLocal institutional review boardInstitutional review boardResearch NetworkREACH projectChart abstractionClinical characteristicsImmunologic profileClinical courseHIV pathogenesisPhysical examinationHIV epidemicStudy populationAdolescent careDisease comorbiditiesClinical experienceMultidisciplinary teamHormonal variationsStudy aimReview board